Background: Epiphora has a significant impact on the patient's quality of life and is commonly caused by nasolacrimal duct obstruction. Dacryocystorhinostomy (DCR) 
D acryocystorhinostomy (DCR) via an external approach has tradi-
tionally been considered the mainstay of treatment for acquired nasolacrimal duct obstruction. [1] [2] [3] The advent of modern fiberoptic endoscopic equipment has fueled interest in an endonasal approach and obviated the need for an external incision. Studies from the last decade showed that endoscopic endonasal DCR compares favorably with external DCR in both the primary and revision setting. 1, [3] [4] [5] [6] [7] Although objective measures such as a patent ostium on irrigation after surgery (anatomic patency) or resolution of epiphora (functional patency) are important criteria in assessing the effectiveness of the operation, patient-reported symptom relief is equally important when assessing success. Constraints in health care resources have drawn many surgical procedures into the spotlight to determine the "best value" interventions. Increasingly, as a result, greater emphasis is being placed on measuring patients' perception of postoperative benefit when assessing the outcome of a particular surgical procedure. 3, 8, 9 There are a number of articles in the literature that focus on the measurement of quality-of-life (QOL) improvement after DCR. 1, 3, [8] [9] [10] [11] The Lacrimal Symptom Questionnaire (Lac-Q) is a well-validated questionnaire developed by Mistry et al., 12 and focuses on assessing the improvement (or lack of improvement) of lacrimal symptomatology as well as the social impact after a DCR. The aim of this study was to prospectively investigate and compare changes in QOL after external and endoscopic DCR.
METHOD
Data were prospectively collected of consecutive DCRs performed by the senior authors (S.N., S.D.) between January 1, 2014, and January 1, 2016, at the Manukau Surgery Centre, New Zealand. Institutional review board-institutional ethics committee approval was obtained, and a prospective analysis was performed for patients who presented with acquired nasolacrimal duct obstruction and who were undergoing DCR. Patients were referred to the Ophthalmology Department and were assessed jointly by the ophthalmologist (S.D.) and otolaryngologist (S.N.) in a joint lacrimal clinic. All the patients received a complete Ear, Nose and Throat (ENT) and ophthalmologic assessment. The patients were offered a choice of either an external or an endonasal procedure; these patients made up the study groups. No randomization for treatment group assignment was carried out. Informed consent was given by each patient.
In all the patients, the diagnosis of lacrimal sac or nasolacrimal duct obstruction was made by clinical assessment as well as by lacrimal syringing and probing to confirm the level of obstruction. When there was uncertainty of the level of obstruction, a dacryocystogram was requested. The most common cause of epiphora was secondary to dacryocystitis, followed by primary nasolacrimal duct obstruction. Exclusion criteria were the presence of cancer and the lack of postoperative follow-up. Children were excluded from the study. A consecutive series of 60 patients who underwent DCR from January 1, 2014, to January 1, 2016 were invited to participate in the study.
Improvement in QOL was assessed by the Lac-Q. All the patients were assessed before surgery and at three postoperative visits (at 4 weeks, 3 months, and 6 months) after the surgery. This is depicted in Tables 1 and 2 . The patient scored the lacrimal symptoms for each eye and the social impact of the condition. The total score was obtained by
adding the social impact scores (0 to 5 points) and the lacrimal symptom scores (0 to 14 for each eye). The results were prospectively recorded and maintained in an electronic data base. Clinical assessment of the surgical outcome was performed by endoscopically visualizing the rhinostomy. Anatomic patency was assessed by using the fluorescein dye disappearance test (FDDT). The same techniques were used to evaluate the patency in both the endoscopic and external DCR groups. The results are summarized in Table 3 .
Surgery
The powered endoscopic DCR technique was previously described. 13 Total intravenous anesthesia with propofol and remifentanil general anesthesia was administered. The nasal mucosa was decongested with neuropatties soaked in a solution of 4 mL of normal saline solution, 2 mL of 4% cocaine, and 1 mL of 1:1000 adrenaline. Topical anesthesia (lidocaine 2% with 1 in 80,000 adrenaline) was injected into the axilla of the middle turbinate and over the frontal process of the maxilla. If an access septoplasty was required, then this was performed endoscopically by using a 0°nasal endoscope.
The endoscopic DCR was performed by using a 30°endoscope. Briefly, a posteriorly based flap was elevated just anterior to the middle turbinate and exposed the frontal process of the maxilla and the lacrimal bone. The lacrimal bone was then disarticulated from the frontal process of the maxilla and removed. By using a Hajek-Kofler forward punch (Karl Storz GmbH, Tuttlingen, Germany), the frontal process was removed. As this bone got thicker, a 15°2.5-mm Curved Diamond DCR Burr (Medtronic Xomed, Inc., Jacksonville, FL) was used to remove the remaining bone and expose the fundus of the sac, which lies 6-8 mm above the axilla of the middle turbinate. The canaliculus was then probed and the sac opened while visualizing the probe in the sac via the endoscope. Larger anterior and smaller posterior sac flaps were created. The lateral nasal wall mucosa was trimmed to cover the superior and inferior exposed bone around the rhinostomy and was reflected back so that it was in apposition with the mucosa of the opened lacrimal sac. When the common canaliculus opening was tight and in revision cases, O'Donoghue tubes were inserted and secured in place with a silastic collar and ligaclips. The tubes were removed at the first postoperative appointment in 4 weeks.
Statistical Analysis
Standard descriptive statistics were reported as median (interquartile range [IQR] ) for continuous variables and as proportions for categorical variables. The association between these variables was examined with independent samples Mann-Whitney U test and 2 test, respectively. The Mann-Whitney U test was used to compare the difference of Lac-Q scores at baseline and after surgery. A subgroup analysis of age-matched subjects was performed. Propensity score analysis was used to match the cohorts for age. This helped account for case selection bias between endoscopic and external DCR groups by estimating the conditional probability of the treatment method in each case based on the matched preoperative variable. Another subgroup analysis that compared patients with anatomically successful surgery in both treatment groups was carried out. This was to determine whether QOL measures were due to anatomic patency or differences in techniques between the two treatment modalities. Statistical analyses were performed by using the statistical software SPSS (IBM Corp., Released 2012, IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY).
RESULTS
Sixty consecutive patients were recruited into the study. One patient in the external DCR group did not attend postoperative followup, was not contactable, and was excluded from the final analysis. In total, 59 patients were included in the analysis (22 in the endoscopic group, 37 in the external group). Patient's age, gender, and length of follow-up for both treatment arms are compared in Table 4 . There was a statistically significant difference between the patients' median age in the two treatment groups (p ϭ 0.003). The Lac-Qs were analyzed in social impact, lacrimal symptom, and total scores.
In the endoscopic group, the preoperative median total Lac-Q score was 13.0 (IQR, 10.5-18.8), whereas the postoperative median total score was 1.0 (IQR, 0-3.8). The median change in total Lac-Q score was 12.0 (IQR, 8.3-16.0). In the external group, the median preoperative total Lac-Q score was 12.0 (IQR, 10.0-18.5), the median postoperative total Lac-Q score was 5.0 (IQR, 0.5-9.5), and the median change in total Lac-Q score was 7.0 (IQR, 3.0-11.0). The median postoperative Lac-Q total score was statistically significantly lower in the endoscopic group compared with the external group (p ϭ 0.005) (Fig. 1) .
In the endoscopic group, the preoperative median social impact score was 5.0 (IQR, 4.0-5.0) and the postoperative median social impact score was 0 (IQR, 0-1.0). The median change in the social impact score was 4.0 (IQR, 2.0-5.0). In contrast, in the external group, the preoperative median social impact score was 4.0 (IQR, 3.0-5.0), and the postoperative median social impact score was 2.0 (IQR, 0-3.0). The median change in the social impact score was 3.0 (IQ, 0.5-4.0). The difference in the change in the median social impact score between the two treatment groups was statistically significant (p ϭ 0.029) (Fig. 2) .
In the endoscopic group, the median preoperative lacrimal symptom score was 8.0 (IQR, 7.0-12.8). The median postoperative score was 0 (IQR, 0-1.8). The median change was 8.0. In the external group, the median postoperative lacrimal symptom score was 8.0 (IQR, 6.0-14.0). The median postoperative score was 4.0 (IQR, 0-7.0). The median change was 4.0. There was a statistically significant (p ϭ 0.014) difference in the change in median lacrimal scores, with those in the endoscopic group with little or no lacrimal symptoms (Fig. 3) .
Surgical Outcome
Of the 59 patients who underwent DCR, 41 patients (21 in the endoscopic DCR group and 20 in the external DCR group) had available postoperative data that described the patency of the rhinostomy and the FDDT outcomes. After endoscopic DCR, 90.4% had a patent rhinostomy as assessed endoscopically when compared with only 60.0% in the external DCR group (p ϭ 0.157). A similar finding was noted in the FDDT outcomes.
Subgroup Analyses
Twenty-two patients who underwent endoscopic DCR were case matched by using propensity score analysis for age with 22 patients who had had external DCR. No statistical significance difference was noted for age, gender, length of follow-up, and surgical success rates. Data for surgical outcomes were available in 14 of 22 patients who underwent external DCR; 8 (57%) had a patent rhinostomy and positive FDDT result after surgery. The pre-and postoperative dif- 
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ference in total Lac-Q scores between endoscopic and external DCRs were statistically significant (median scores, 10.0 and 7.5, respectively; p ϭ 0.009). A similar trend was noticed when it came to the differences in social impact scores (median, 4.0 versus 3.0; p ϭ 0.005) and lacrimal symptom scores (median, 7.0 versus 4.5; p ϭ 0.037). The Lac-Q scores among the patients with anatomically successful surgery (defined as a patent rhinostomy and positive FDDT result after surgery) were compared. There were 19 patients in the endoscopic group and 12 patients in the external group who fulfilled these criteria. The pre-and postoperative differences in total Lac-Q scores between endoscopic and external DCR were statistically significant (median scores, 11.0 and 8.0, respectively; p ϭ 0.008). A similar pattern was observed in terms of the differences in social impact 
DISCUSSION
Epiphora is an important presenting symptom of acquired nasolacrimal duct obstruction. It causes blurred vision and eyelid irritation. Patients may also report difficulty reading and social embarrassment, 14 which can adversely affect the patient's perception of wellbeing. 1, 7, 15 In the present study, we demonstrated that both endoscopic DCR, endonasal and external, can lead to a reduction of symptoms and an improvement in QOL by using a validated questionnaire. The magnitude of improvement seemed to be greater in the 
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endoscopic group. To our knowledge, this was the first prospectivecohort study to compare patient-reported outcome measures between external and endoscopic DCR groups when using the Lac-Q. There were two main issues with our study. First, the difference in median age between the two treatment groups indicated that there existed a selection bias. We attempted to address this by performing a subgroup analysis and found that the differences in Lac-Q scores still existed, even when the cohorts were matched for age. Second, and perhaps more importantly, the relatively lower postoperative anatomic patency rate in the external DCR group may explain the less favorable Lac-Q scores seen in this group.
Fundamentally, there are two ways of evaluating the success of DCR. The first is to define anatomic success. This was characterized by a patent rhinostomy on endoscopic examination, patent lacrimal system on irrigation, or passage of fluorescein dye as confirmed endoscopically in the nasal cavity on postoperative endoscopy. 5, [16] [17] [18] [19] The second method was by evaluating the patient's perception of benefit or symptom resolution after the procedure, 16 which can range from simply asking the patient if his or her epiphora resolved after the operation 5 or by using a questionnaire in an attempt to objectively quantify the degree of symptomatic improvement and residual burden of symptoms if present. 3, 10, 12, 15 Previous studies highlight a lack of concordance between objective findings and patient satisfaction. 1, 18, 20 The term "lacrimal paradox" has been used to describe this phenomenon, in which anatomic success may not necessarily lead to adequate control of symptoms. 21 It is hypothe- sized that lacrimal paradox may be attributable to resistance within the nasolacrimal drainage system rather than the actual patency of the drainage system. This is more common in functional obstruction (lacrimal pump failure), where, before surgery, the lacrimal system is patent on syringing but the patient still has symptoms of epiphora. Furthermore, the effect of anatomic success may only have positive effects on the severity of epiphora and may not accurately reflect the broader range of QOL changes. 14 In the present study, we wanted to evaluate the patient's perception of subjective improvement and to assess the impact of the procedure on the patient's social scale.
There are a number of tools that allow measurements of improvement in symptoms and QOL after surgery. The Glasgow Benefit Inventory (GBI) has been extensively used in otolaryngology. 15, 22, 23 The GBI assesses the general perception of well-being, including the social and psychological components that contribute to health. A multicenter prospective nonrandomized study that compared 77 patients (37 who had external DCR versus 40 who had endonasal DCR) found that both techniques resulted in positive health status changes as reflected by changes in GBI scores. 24 Other studies also used GBI to assess the effectiveness of endonasal DCR [1] [2] [3] 25 ; one study that used GBI to compare the benefits of endoscopic laser-assisted DCR versus external DCR. 10 Although GBI is a well-validated research tool, the use of a generic health questionnaire that focuses on improvement in general health states may not be entirely appropriate for DCR because GBI lacks applicability and preciseness to the lacrimal symptom. Also, it may not be an optimal tool for evaluating health states in elderly patients with multiple comorbidities. 3 The first real attempt at using a lacrimal symptom-specific questionnaire was by Smirnov et al. 8 by using the Nasolacrimal Duct Obstruction Symptom Score (NLDO-SS) questionnaire. This questionnaire was subsequently validated in another study in 2014. 11 The NLDO-SS questionnaire is composed of five items that focus on common ocular symptoms in nasolacrimal duct obstruction. In their pilot study, it was demonstrated that there was a statistically significant correlation between GBI and the NLDO-SS questionnaire. 8 The NLDO-SS questionnaire measures symptoms related to nasolacrimal duct obstruction and has no provision for social impact. It, however, does have questions on nasal obstruction and discharge, which may have a bearing on the patient's overall well-being. 8, 11 The Lac-Q developed by Mistry et al. 12 was used in 17 patients who were undergoing 22 DCR procedures, and showed a significant reduction in the Lac-Q scores after the operation. The Lac-Q is a validated lacrimal symptomatology scoring system based on two broad categories of eye-specific scores and social impact. It is unique in that it assesses both lacrimal-specific symptoms and the overall QOL. Lac-Q serves to evaluate the general perception of well-being, including the social and psychological components that contribute to health from an lacrimal symptomatology standpoint. It is different from the GBI because the Lac-Q is administered before and after surgery. Researchers from Hyderabad, India, applied the Lac-Q on 50 patients who underwent a total of 55 powered endoscopic DCR and found that the postoperative scores corroborated with the success rates from an anatomic standpoint. 26 They concluded that the Lac-Q is a "simple and useful tool to evaluate the quality of outcomes of powered endoscopic dacryocystorhinostomy". 26 Some studies used nonvalidated, self-devised questionnaires to assess the effectiveness of DCR. The use of different questionnaires hampers the effort to compare outcomes between different centers and also means that reproducibility cannot be evaluated. 3, 4, 14, 18 Tripathi et al. 20 used a self-devised questionnaire to enquire about the extent of epiphora after laser endonasal endoscopic DCR, with 65% of the subjects reporting a complete cure. Curiously, 91% of the patients were noted to have objective success as indicated by sac washout. 20 Desirable features of a questionnaire would be uniformity, exhaustiveness, sensitive enough to capture the effect of the intervention, and ease of use. 1, 8 The clinicians involved in this study found that the Lac-Q was easy to apply and intuitive. The results indicated that it is sufficiently sensitive to capture the magnitude of change in lacrimal symptoms and social impact after DCR. The questionnaire can be routinely used in the clinical assessment of patients with lacrimal symptoms and serve as a useful tool in the clinician's armamentarium.
The literature is replete with studies that purport the advantages of endoscopic endonasal DCR and includes greater cosmetic acceptability with no external scar, with 10% of patients with external DCR reporting a cosmetically unacceptable result. 6 Endoscopic DCR avoids division of the medial canthal ligament, which carries less risk of interfering with the physiologic lacrimal pump mechanism. 3, 5, 10 Previous meta-analyses showed that endoscopic DCR is associated with lower bleeding, infection, and revision rates, albeit not statistically significantly. 6 Endoscopic DCR also permits simultaneous management of intranasal pathology, such as a deviated nasal septum or sinusitis, which may be driving the lacrimal symptoms. When using cost analysis, a study from the United Kingdom indicated that the endoscopic DCR surgery is more cost effective than external DCR. 27 Finally, because the lacrimal sac is fully marsupialized and directly inspected, suspicious pathology can be easily biopsied if required.
Although this study was conducted prospectively on a consecutive series of patients, the lack of randomization meant that there was a component of selection bias. The patients were older in the external group, and this may have skewed the results of the questionnaire. Selection bias was still a significant consideration, and the differences in healing due to age or other unidentified variables between the nonrandomly selected groups may have accounted for some of the differences observed in our study. The investigators were not blinded during retrospective chart review. The patients with better outcomes may have been less likely to return for their follow-ups and, therefore, may have subjected our results to less favorable outcomes.
We acknowledge that the incomplete data in the postoperative assessment of anatomic patency of ductal system, especially in patients who had external DCR was a weakness in our study. When the available data were analyzed, it became apparent that the anatomic success rate in external DCR was lower when compared with endoscopic DCR, although this difference did not reach statistical significance.
More importantly, the anatomic patency rate of external DCR in our study was lower (60%) than reported in previous series. 17, 18, 28, 29 We conceded that the differences in Lac-Q scores between the two treatment groups may have been unfairly influenced by the increased number of anatomic failures in the external group and could not be attributed solely to a perceptive difference of QOL improvement alone among the patients. Nevertheless, subgroup analysis of patients who had preserved anatomic patency after surgery indicated that the differences in QOL between the two treatment groups remained statistically significant.
CONCLUSION
Endoscopic endonasal and external DCR can lead to reduction of symptoms and improvement in QOL by using a validated questionnaire. The magnitude of difference seemed to be greater in the endoscopic group when compared with the external group for both social and functional impact. The differences in the median age and anatomic patency rates between patients in the two treatment modalities may have had a non-negligible influence on the QOL outcome measure. Future prospective randomized studies are required to ensure that the differences seen are independent of neo-ostial patency status or age difference.
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